Bipolar Disorder treatment in Eatontown, New Jersey

Bipolar disorder is a mood condition defined by distinct episodes — periods of elevated mood (mania or hypomania) alternating with periods of depression, with stable functioning between episodes. The DSM-5-TR — the current diagnostic manual — recognizes several distinct bipolar conditions, each with its own clinical course and treatment implications.

About 2.8% of U.S. adults experience bipolar disorder in any given year, per NIMH data. Lifetime prevalence is roughly 4.4%. Onset is most often in late adolescence or early adulthood; the average age of first manic or hypomanic episode is around 18 to 22.

A clinical detail that matters: bipolar disorder is the most-misdiagnosed major psychiatric condition. The average gap between first symptoms and correct diagnosis is 5 to 10 years. The depression episodes typically come first, often years before any manic or hypomanic episode, and are often diagnosed and treated as major depressive disorder. The diagnosis updates only when an elevated-mood episode appears, sometimes triggered by an antidepressant prescribed for the depression. This is part of why the antidepressant question in bipolar care matters so much (Section 4 below).

We don't diagnose in copy on a website. The criteria below help frame what bipolar disorder looks like clinically. The actual diagnosis happens in a psychiatric evaluation, usually 60 to 90 minutes long, with a careful review of mood history across years — not just the present episode. Family history matters; bipolar disorder is among the most heritable psychiatric conditions.

What separates bipolar disorder from major depression: the presence at some point of a manic or hypomanic episode. What separates it from typical mood swings: the duration, intensity, and functional impact of those episodes.

The DSM-5-TR distinguishes several bipolar conditions. They share underlying biology and overlap clinically, but they have different course patterns and different treatment implications.

Bipolar I disorder. Defined by at least one full manic episode in the patient's lifetime. A manic episode is a distinct period of abnormally elevated, expansive, or irritable mood plus increased activity or energy, lasting at least one week (or any duration if hospitalization is required). Mania involves significant impairment in functioning and may include psychotic features (delusions, hallucinations) in severe cases. Most patients with bipolar I also have depressive episodes, though a minority don't. Bipolar I is the most-recognized form of the condition.

Bipolar II disorder. Defined by at least one hypomanic episode and at least one major depressive episode, with no full manic episode. Hypomania is not just "less severe mania" — it's a distinct clinical state. The diagnostic threshold is at least four consecutive days of elevated mood plus increased energy, with observable changes in functioning. Hypomania doesn't cause the marked impairment of mania and doesn't include psychotic features. Patients with bipolar II often have more time in depressed states than in elevated states, which is part of why bipolar II is frequently misdiagnosed as recurrent major depression.

Cyclothymic disorder (cyclothymia). A chronic, lower-grade mood condition with hypomanic and depressive symptoms that don't fully meet criteria for hypomania or major depression, present for at least two years. Cyclothymia can progress to bipolar I or II in some patients; in others it remains a chronic milder pattern.

Mixed features (DSM-5-TR specifier). A specifier that applies when manic or hypomanic and depressive features are present simultaneously. Mixed states — manic energy plus depressive content — are clinically dangerous: suicide risk is elevated, judgment is impaired, and the combination of energy and despair is corrosive. Mixed-features presentations require careful psychiatric monitoring and are generally treated more aggressively than single-pole episodes.

Rapid cycling. Four or more mood episodes in a 12-month period. Rapid cycling is often associated with antidepressant exposure in undiagnosed bipolar disorder and with thyroid abnormalities. Treatment usually involves switching from antidepressants to mood stabilizers and screening for contributing factors.

Bipolar disorder is often diagnosed late because the depressive episodes come first and look like depression. Many patients have been treated for "depression" for years before a manic or hypomanic episode reframes the diagnosis. If you've had depressive episodes that haven't responded well to antidepressants, or if antidepressants have produced an unusual high-energy or agitated state, that's information worth bringing to a psychiatric evaluation.

If you've never had a manic or hypomanic episode, the question may not be bipolar disorder. If you have, here's what those episodes typically look like.

Manic and hypomanic episode features: decreased need for sleep (sleeping 3-4 hours and feeling rested), racing thoughts, pressured speech, dramatically increased energy, grandiose self-perception, impulsive decisions (financial, sexual, work), risk-taking that's out of character, and — in mania specifically — sometimes psychotic features. Hypomania is often pleasurable; mania more often has irritable or paranoid features. Both are abnormal. Both deserve evaluation.

Mixed-features episodes: energy and agitation paired with despair, hopelessness, or suicidality. This is the highest-acuity bipolar presentation by suicide risk.

Depressive episodes in bipolar disorder look like depression elsewhere — see our depression page for the broader symptom picture. The clinical distinction comes from the lifetime presence of an elevated-mood episode.

If you're having thoughts of suicide or feeling unsafe, call or text 988 for the Suicide and Crisis Lifeline. Available 24/7. New Jersey residents can also reach the NJ Hopeline at 1-855-654-6735. Bipolar disorder has elevated suicide risk, particularly during mixed states and during the early years after diagnosis. If you're in immediate physical danger, call 911 or go to the nearest emergency room. We are an outpatient clinic; an active suicidal crisis or active mania with impaired judgment requires a higher level of care.

The list below collects symptoms patients commonly bring to a bipolar-focused first visit. It's not a diagnostic tool. If several resonate, that's information worth bringing to a clinician.

This is the highest-stakes clinical claim on the page. Standard antidepressants (SSRIs, SNRIs) used alone in bipolar disorder can trigger manic or hypomanic episodes, can induce rapid cycling, and can destabilize patients whose mood was previously controlled. The risk is real and well-documented. The safer first-line approach in bipolar disorder is mood stabilizers, with antidepressants used only alongside a mood stabilizer if at all.

This is part of why correct diagnosis matters so much. A patient with undiagnosed bipolar II who is treated with an SSRI for the depressive episodes may have a manic or hypomanic episode that re-frames the diagnosis. The episode itself is the consequence of treating one face of bipolar disorder without recognizing the underlying condition.

If you are currently on an antidepressant for what's been called "depression" and you suspect bipolar disorder, do not stop the antidepressant on your own. Abrupt discontinuation can cause a discontinuation syndrome and can also destabilize mood. Bring the question to a psychiatric visit. We review the medication picture carefully, take a thorough mood history, and adjust the regimen with a deliberate plan — usually adding a mood stabilizer first, then tapering or continuing the antidepressant depending on how you respond.

The principle: in bipolar care, the question is rarely "should I be on an antidepressant" alone. It's "what mood stabilizer is the foundation, and does an antidepressant fit on top of that foundation."

Several mood stabilizers are first-line for bipolar disorder. The right choice depends on which phase predominates (manic vs. depressive vs. mixed), severity, prior medication history, and your priorities around side effects and monitoring.

Lithium. The gold standard mood stabilizer with the strongest evidence base of any psychiatric medication. Lithium reduces manic episodes, depressive episodes, and — uniquely among mood stabilizers — has the strongest anti-suicide evidence of any psychiatric medication. It's effective, generic, and inexpensive. The trade-off: lithium requires regular blood-level monitoring (every 3 to 6 months at steady state), kidney and thyroid monitoring, and dose adjustments around dehydration and other medications. For many patients, the monitoring is the price of the most-effective treatment available.

Lamotrigine (Lamictal). Best for bipolar depression specifically — has the strongest evidence among mood stabilizers for preventing depressive episodes in bipolar II in particular. Lamotrigine has fewer day-to-day side effects than lithium and doesn't require routine blood monitoring. The main caveat is the slow titration required because of a rare but serious skin reaction (Stevens-Johnson syndrome) if dose is increased too quickly. The titration takes 5 to 6 weeks to reach therapeutic dose, which means lamotrigine isn't the right choice for an acute bipolar depressive episode that needs faster response.

Valproate (Depakote). Effective for manic episodes and mixed states. Often used in patients who haven't tolerated lithium or who present with mixed features. Side effects include weight gain, GI distress, and tremor; valproate is teratogenic, so it's avoided in patients of reproductive age who could become pregnant.

Carbamazepine (Tegretol). An older mood stabilizer still used in some cases, particularly for treatment-resistant bipolar disorder. Drug interactions are extensive (carbamazepine induces multiple liver enzymes), which complicates regimens.

Atypical antipsychotics with mood stabilizer effect. Several atypical antipsychotics are FDA-approved for bipolar disorder:

• Quetiapine (Seroquel) — approved for both manic and depressive episodes; useful as monotherapy
• Lurasidone (Latuda) — specifically approved for bipolar depression
• Olanzapine (Zyprexa) — strong efficacy in mania; combined with fluoxetine (Symbyax) for bipolar depression
• Aripiprazole (Abilify) — approved for mania and as adjunctive treatment

Atypical antipsychotics work fast (often within 1-2 weeks for acute mania), which is why they're often the first medication added during an acute episode. The trade-off is metabolic side effects (weight gain, glucose, lipids) that require monitoring.

The honest framing. Choosing the right mood stabilizer is a careful clinical decision shaped by which phase of the illness predominates, prior medication history, monitoring tolerance, and pregnancy considerations. Many patients end up on a combination — for example, lithium plus lamotrigine, or lithium plus an atypical antipsychotic — rather than monotherapy.

Medication is the foundation of bipolar treatment, but therapy adds meaningful gains across long-term outcomes — fewer relapses, better adherence, better functioning between episodes. Three therapy approaches have specific evidence for bipolar disorder.

Cognitive Behavioral Therapy (CBT) for bipolar disorder. Adapted from standard CBT to address bipolar-specific patterns: identifying early warning signs of mood episodes, cognitive restructuring for both manic grandiosity and depressive hopelessness, and behavioral strategies for stabilizing routines. CBT for bipolar disorder typically runs 12 to 20 sessions of about 50 minutes each. Best evidence is for relapse prevention and for managing depressive episodes.

Interpersonal and Social Rhythm Therapy (IPSRT). A bipolar-specific therapy developed by Ellen Frank that combines interpersonal therapy (focused on grief, role transitions, conflicts) with attention to daily routines — sleep, meals, social activity. The principle: stabilizing biological rhythms reduces mood-episode triggers. IPSRT is delivered in 16 to 20 sessions and has strong evidence for time-to-relapse outcomes.

Family-Focused Therapy (FFT). Involves family members in psychoeducation about bipolar disorder, communication-skills work, and problem-solving training around the patient's specific stressors. FFT has particularly strong evidence in bipolar adolescents and in patients living with their family of origin during early-stage treatment. It's typically delivered in 21 sessions over 9 months.

What we offer. Our therapy team includes clinicians familiar with all three approaches. The right fit depends on what's driving instability for you specifically. Patients whose episodes are tied to sleep disruption and irregular routines often do best with IPSRT. Patients whose depressive episodes are dominant often do best with CBT. Patients living with significant family conflict often benefit from family-focused work. Many patients combine elements across approaches.

Therapy doesn't replace medication for bipolar disorder. The combination outperforms either alone for relapse-prevention and inter-episode functioning. For the broader services framework, see our therapy page.

Bipolar disorder rarely occurs alone. Most patients with bipolar disorder also meet criteria for at least one other psychiatric condition. The most common patterns:

Bipolar + anxiety disorders. Roughly 60% of patients with bipolar disorder also meet criteria for an anxiety disorder. Generalized anxiety, panic disorder, and social anxiety are most common. Treatment usually focuses on the bipolar foundation first; many anxiety symptoms reduce when mood is stable. Persistent anxiety often responds to the same mood stabilizers used for the bipolar disorder; benzodiazepines are used cautiously and short-term.

Bipolar + substance use. Substance use is more common in bipolar disorder than in any other major psychiatric condition. Alcohol, cannabis, and stimulants are the most common — often used to manage mood episodes. The combination complicates treatment because substances destabilize mood and undermine medication effectiveness. We treat co-occurring substance use alongside bipolar care; Joseph Vacchiano on our team is dual-licensed as an LCADC.

Bipolar + ADHD. Genuine ADHD comorbidity exists and requires careful diagnosis (ADHD symptoms can resemble hypomanic features and the distinction matters for treatment). When both are present, the bipolar condition is stabilized first; ADHD treatment is added carefully because stimulants can destabilize mood in some patients.

Sleep. Sleep regulation is central to bipolar care. Reduced sleep is one of the earliest warning signs of an emerging manic episode. Maintaining a consistent sleep-wake schedule reduces episode risk. We address sleep directly as part of treatment — sometimes with medication targeting sleep, often with behavioral sleep work, almost always with structured sleep monitoring.

Thyroid function. Lithium specifically can affect thyroid function, and bipolar disorder is associated with higher thyroid dysfunction rates regardless of medication. We monitor thyroid status regularly in patients on lithium.

The point: bipolar care is rarely just about the mood condition. Most treatment plans address sleep, comorbid anxiety, sometimes substance use, and ongoing medical monitoring as integrated parts of the work.

Honest answer: bipolar disorder is a chronic condition, and most patients benefit from long-term medication maintenance. The treatment timeline isn't measured in months to a finish line; it's measured in stability and reduced relapse over years.

Acute episode stabilization. A manic, hypomanic, or depressive episode usually responds to medication adjustment within 2 to 8 weeks. Severe mania can require hospitalization; we coordinate with hospital programs when that level of care is needed.

Maintenance medication. After a first manic or mixed episode, current guidelines generally recommend continuing mood stabilizer treatment for at least 12 months — and often indefinitely for patients with multiple prior episodes, severe presentations, or strong family history. Lithium remains effective long-term in many patients who tolerate it.

Therapy course. CBT and IPSRT for bipolar disorder are typically 16-20 session courses, often followed by maintenance sessions every 4-12 weeks. Family-focused therapy runs 9 months as designed.

Monitoring intervals. Medication-management visits are typically every 4 to 6 weeks during stabilization and every 8 to 12 weeks once stable. Lithium blood levels and kidney/thyroid function are checked every 3 to 6 months. Patients on atypical antipsychotics need metabolic monitoring (fasting glucose, lipids, weight) every 3 to 6 months.

Relapse prevention. Most relapses follow a recognizable pattern: sleep disruption, life stressor, medication non-adherence, or substance use. Early-warning-sign work — identifying the specific personal patterns that have preceded prior episodes — is built into treatment so you and your clinician can intervene early.

The long view. With consistent treatment, most patients with bipolar disorder achieve substantial mood stability and live full lives between episodes. We don't promise no future episodes. We do promise that the work is collaborative, that medication management is careful, and that the goal is the longest stable periods possible — not just acute-episode response.